Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 23, 2024

BUY
$0.22 - $0.58 $3,608 - $9,512
16,400 Added 100.35%
32,743 $8,000
Q3 2023

Nov 08, 2023

BUY
$0.47 - $1.87 $7,681 - $30,561
16,343 New
16,343 $9,000

Others Institutions Holding MYMD

About MyMD Pharmaceuticals, Inc.


  • Ticker MYMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,470,000
  • Market Cap $67.5M
  • Description
  • MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and o...
More about MYMD
Track This Portfolio

Track Lvz, Inc. Portfolio

Follow Lvz, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lvz, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Lvz, Inc. with notifications on news.